TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
3月 05, 2026
2 min read
45

The Belgian stock market ended Thursday's session on a negative note. The benchmark BEL 20 index recorded a significant decline of 1.01 percent, reflecting broad investor caution.
The downturn was led by poor performance in several key industries. The Technology, Healthcare, and Utilities sectors experienced notable losses, contributing to the overall market slide. On the Brussels Stock Exchange, falling stocks outnumbered advancing ones by a margin of 60 to 31, with 15 remaining unchanged.
Among the index's components, Melexis NV (EBR:MLXS) was the worst performer, falling 4.23 percent. Cofinimmo SA (EBR:COFB) and Argen-X (EBR:ARGX) also saw significant drops of 3.62 percent and 2.55 percent respectively.
In contrast, Elia (EBR:ELI) emerged as the top gainer, with its shares rising 2.73 percent. Azelis Corporate Services NV (EBR:AZE) and Syensqo SA (EBR:SYENS) also posted gains.
The market's performance indicates bearish sentiment, particularly within the tech and healthcare spaces. Investors will be watching to see if this trend continues in the upcoming sessions.
Q: Why did the BEL 20 index fall?
A: The decline was primarily driven by losses in the Technology, Healthcare, and Utilities sectors.
Q: Which company was the worst-performing stock on the BEL 20?
A: Melexis NV (EBR:MLXS) was the session's worst performer, with a decline of 4.23 percent.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles